Search

everythinglearnresearchcommunity

for

Search:↓

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

Lithium poisoning can cause severe health complications and requires careful monitoring.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Natural products may be safer and effective alternatives for managing heart attacks.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

Antiandrogens don't help with COVID-19 and aren't recommended.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

New genetic mutations linked to rare skin disorders were found in three newborns.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Females are more likely than males to experience long-COVID symptoms and heart issues.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Genetic differences affect how people respond to COVID-19.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

More symptoms during initial COVID infection increase the risk of long-term effects.